Home
Profile
Manufacturing
Quality Control
Products
  Contact Us Careers Sitemap          
   
 
:: Research & Development
:: International Collaboration
:: Business Opportunities
:: Latest Events
:: Divisions At a Glance


  press_release_btn_otherspg :: Press Releases vline_separator

  :: In Licensing   inlicensing_btn__otherspg vline_separator

  outlicensing_btn_otherspg :: Out Licensing vline_separator

 
  Piperacillin and Tazobactam for Injection 4.5 g
  Indications :
 

Appendicitis and Peritonitis

Uncomplicated and complicated skin and soft tissue infections

Pelvic inflammatory diseases

Community acquired pneumonia

Nosocomial pneumonia due to S. aureus

   
  Dosage :
  Children >12 years and Adults :

Nosocomial pneumonia:
I.V. : Piperacillin / tazobactam 4 / 0.5 g every 6 hours for 7-14 days.

Severe infections :
I.V. : Piperacillin / tazobactam 4 / 0.5g every 8 hours or 3/0.375 g every 6 hours for 7-10 days.

Moderate infections :
I.M. : Piperacillin / tazobactam 2 / 0.25g every 6-8 hours; treatment should be continued for 7-10 days depending on severity of disease.

Paediatric : 112.50mg/kg TID (age 9 months or older).

90mg/kg TID (age 2months - 9months).

Renally Impaired Patients :

piperacillin_tazobactam_renal_table

   
  Packing : 10 Vials of 4.5 g
 



  Home | Careers | Site map | Contact Us



 
  All contents copyright © United Biotech (P) Limited, All rights reserved.